drugset / Trial / NCT07476963

Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects

NCT07476963

Phase 1 Active not recruiting 18 enrolled Forward Pharmaceuticals Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A Phase I, Single-Center, Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Effect of High-Fat and Low-Fat Meals on the Pharmacokinetics of FWD1802 in Chinese Healthy Subjects. The primary objectives are to address the following questions: To evaluate the impact of high-fat and low-fat meals on the pharmacokinetic (PK) characteristics of a single oral dose of FWD1802 in healthy Chinese Subjects.

Timeline

Start
2026-03-15
Primary completion
2026-07-06
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject FWD1802 Unknown 150 mg Oral

Indications

No indication recorded.